Clinical application of PGx: heating up
Online in TechNewsWorld, writer Sonia Arrison described talks discussions at the the Personalized Medicine World Conference held in early January. PharmGKB PI Russ Altman described the team’s effort to markup the whole genome sequence reported by his colleague last August.
The reporter concluded that "it is possible to predict how someone will respond to certain drugs, such as warfarin". In addition to our own efforts, we are excited to see increasing movement of pharmacogenetics knowledge towards clinical application. We all knew this would happen, but we are aware of numerous efforts around the country to try to deploy pharmacogenetics in clinical practice. This is great.
(PharmGKB curator Connie Oshiro and I thank Alisa Zapp Machalek at NIH for bringing this to our attention.)
The reporter concluded that "it is possible to predict how someone will respond to certain drugs, such as warfarin". In addition to our own efforts, we are excited to see increasing movement of pharmacogenetics knowledge towards clinical application. We all knew this would happen, but we are aware of numerous efforts around the country to try to deploy pharmacogenetics in clinical practice. This is great.
(PharmGKB curator Connie Oshiro and I thank Alisa Zapp Machalek at NIH for bringing this to our attention.)